Literature DB >> 7536763

Treatment of cutaneous sarcoidosis with tranilast.

H Yamada1, A Ide, M Sugiura, S Tajima.   

Abstract

Tranilast is an anti-allergic drug clinically used for the treatment of atopy or urticaria. The drug has been shown to have an anti-fibrotic effect as well. We treated two cutaneous sarcoidosis patients with tranilast, resulting in remission within three months of administration. This drug should be an excellent tool for the treatment of other granulomatous diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536763     DOI: 10.1111/j.1346-8138.1995.tb03361.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Idiopathic mediastinal fibrosis: report of a case.

Authors:  S Kinugasa; S Tachibana; M Kawakami; T Orino; R Yamamoto; S Sasaki
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 2.  Sarcoidosis and Its Dermatological Manifestations: A Narrative Review.

Authors:  Jancy Koneti; Swathi Priya Cherukuri; Sai Gadde; Revanth Kalluru; Rahul Chikatimalla; Thejaswi Dasaradhan
Journal:  Cureus       Date:  2022-08-16

3.  Precursor-Directed Combinatorial Biosynthesis of Cinnamoyl, Dihydrocinnamoyl, and Benzoyl Anthranilates in Saccharomyces cerevisiae.

Authors:  Aymerick Eudes; Veronica Teixeira Benites; George Wang; Edward E K Baidoo; Taek Soon Lee; Jay D Keasling; Dominique Loqué
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

4.  Late onset oral treatment with tranilast following large myocardial infarction has no beneficial effects on cardiac remodeling and mortality in rats.

Authors:  Stefan Betge; Christian Kunz; Hans Figulla; Christian Jung
Journal:  Exp Ther Med       Date:  2014-10-06       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.